S. Sosso

发表

Evaluation of a collaborative model for successful implementation of a National CD4 enumeration EQA program in Cameroon

G. Nchinda, A. Meyers, P. Sandstrom, 2021, Scientific reports.

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens

V. Colizzi, C. Perno, S. Billong, 2020, Antimicrobial Resistance & Infection Control.

High concordance in SARSCoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon

V. Colizzi, C. Perno, N. Ndembi, 2022, Journal of public health in Africa.

Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”

V. Colizzi, C. Perno, S. Billong, 2019, AIDS Research and Therapy.

Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaoundé, Cameroon

V. Colizzi, J. Torimiro, J. Fokam, 2020, Virology Journal.

HPV Positivity and Risk of Cervical Cancer according to HIV-Infection: A Comparative Assessment in the Population of Cameroonian Women

V. Colizzi, S. Billong, Z. Sando, 2021 .

Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon

J. Fokam, A. Ndjolo, S. Sosso, 2020, bioRxiv.

Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol

V. Colizzi, C. Perno, J. Fokam, 2022, PloS one.

Archiving of mutations in HIV‐1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP‐READY study

V. Colizzi, C. Perno, M. Santoro, 2021, HIV medicine.

Evaluation of a collaborative model for successful implementation of a National CD4 enumeration EQA program in Cameroon

G. Nchinda, A. Meyers, P. Sandstrom, 2020, Scientific Reports.

Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)

V. Colizzi, C. Perno, N. Kamgaing, 2019, BMC Pediatrics.

Performance of the BD FACSPresto near to patient analyzer in comparison with representative conventional CD4 instruments in Cameroon

G. Nchinda, A. Nanfack, A. Ndjolo, 2020, AIDS Research and Therapy.

Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000

V. Colizzi, C. Perno, N. Ndembi, 2022, Journal of public health in Africa.

Measure of Viral Load by Using the Abbott Real-Time HIV-1 Assay on Dried Blood and Plasma Spot Specimens Collected in 2 Rural Dispensaries in Cameroon

F. Lucht, B. Pozzetto, T. Bourlet, 2009, Journal of acquired immune deficiency syndromes.

High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians.

M. Andreoni, V. Colizzi, C. Perno, 2016, Current HIV research.

High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness

V. Colizzi, C. Perno, Z. Sando, 2022, IJID Regions.

Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings

C. Tchiégang, A. Nanfack, A. Ndjolo, 2020, BMC Infectious Diseases.

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

F. Ceccherini‐Silberstein, C. Perno, V. Colizzi, 2021, HIV medicine.

Undiagnosed Chronic Hepatitis B Infection and HIV Type 1 Drug Resistance Profile in AIDS Patients Receiving Tenofovir-containing Antiretroviral Regimens: Considerations for Monitoring Resistant HIV Variants during Treatment

C. Kouanfack, J. Torimiro, M. Kowo, 2018 .

Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy

J. Torimiro, A. Nanfack, K. Njefi, 2018, BMC Pregnancy and Childbirth.

Intestinal Parasites Infections among HIV Infected Children Under Antiretrovirals Treatment in Yaounde, Cameroon.

C. Lozupone, N. Kamgaing, C. Nkenfou, 2020, Journal of tropical pediatrics.

Evaluation of Virologic Methods for Early Detection of HIV-1 in a Resource-limited Setting: Performance and Cost Analysis

J. Torimiro, C. Nkenfou, S. Sosso, 2013 .

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Viruses.

Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Microbiology spectrum.

High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, Diagnostic microbiology and infectious disease.

HIV-1 Drug Resistance and Genetic Diversity among Vertically Infected Cameroonian Children and Adolescents

V. Colizzi, F. Njiokou, C. Perno, 2020, Exploratory Research and Hypothesis in Medicine.

The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies

F. Ceccherini‐Silberstein, N. Kamgaing, C. Nkenfou, 2023, PloS one.

Feasibility Study of HIV Sentinel Surveillance using PMTCT data in Cameroon: from Scientific Success to Programmatic Failure

O. Bolu, Georges Nguefack-Tsague, S. Billong, 2017, BMC Infectious Diseases.

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2019, BMC Infectious Diseases.

HIV-1 Early Infant Diagnosis is an Effective Indicator of the Prevention of Mother-to-Child Transmission Program Performance: Experience from Cameroon.

V. Colizzi, S. Billong, C. Nkenfou, 2015, Current HIV research.

Evaluation of archived drug resistance mutations in HIV‐1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID‐19 pandemic

F. Ceccherini‐Silberstein, Y. Boum, V. Colizzi, 2023, HIV medicine.

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Scientific Reports.

Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, The Journal of antimicrobial chemotherapy.

Cord blood Vγ2Vδ2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity.

V. Colizzi, R. Leke, C. Pauza, 2014, The Journal of infectious diseases.

Challenges faced by the HIV testing system in low- and middle-income countries

A. Nanfack, J. Fokam, A. Ndjolo, 2023, African Journal of Laboratory Medicine.

High viremia and Poor Immunity are Potential Surrogates of Anti-toxoplasmic Immunoglobulin G Quantification among HIV-Infected Individuals: A Cross-sectional Study in Yaoundé, Cameroon

V. Colizzi, J. Fokam, A. Ndjolo, 2020 .

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics

V. Colizzi, C. Perno, S. Billong, 2023, Medicine.

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé

V. Colizzi, A. Nanfack, J. Fokam, 2019, BMC Research Notes.

Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population

V. Colizzi, S. Billong, Z. Sando, 2023, Journal of Public Health in Africa.

COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde: Lessons from the early phase of the pandemic in Cameroon

V. Colizzi, K. C. Nwosu, O. Keiser, 2023, PLOS global public health.

Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis

V. Colizzi, C. Perno, J. Fokam, 2023, Pathogens.

Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies

F. Ceccherini‐Silberstein, C. Montesano, V. Colizzi, 2023, Frontiers in immunology.

Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa

F. Ceccherini‐Silberstein, V. Colizzi, M. Santoro, 2024, Journal of virus eradication.

Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness

V. Colizzi, J. Fokam, A. Ndjolo, 2024, Frontiers in public health.